SMTL ID : 7qi1.1

Crystal structure of human 14-3-3 protein beta in complex with CFTR peptide pS753pS768 and PPI stabilizer CY007424

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.76 Å

Oligo State

hetero-4-2-mer

Ligands

2 x ARG: ARGININE(Non-covalent)

ARG.1: 7 residues within 4Å: Chain A: N.57 Chain E: R.229 Ligands: Q95.2, Q95.3, TYR.5, GLN.6, TYR.8 4 PLIP interactions: 1 interactions with chain E, 2 Ligand-Ligand interactions, 1 interactions with chain A Water bridges: E:T.233, R.1 Hydrogen bonds: Y.8, A:N.57 ARG.4: 6 residues within 4Å: Chain B: E.24, Y.26, N.57, A.61 Ligands: Q95.3, GLN.7 2 PLIP interactions: 2 interactions with chain B Hydrogen bonds: B:N.57, B:N.57

2 x Q95: [2-(2-methylphenyl)sulfanylphenyl]methanamine(Non-covalent)

Q95.2: 10 residues within 4Å: Chain A: R.63, S.64, R.67, V.68 Chain C: R.5 Ligands: ARG.1, Q95.3, TYR.5, GLN.6, TYR.8 5 PLIP interactions: 2 Ligand-Ligand interactions, 3 interactions with chain A Hydrophobic interactions: R.1, A:R.67, A:V.68 Hydrogen bonds: R.1 pi-Cation interactions: A:R.67 Q95.3: 12 residues within 4Å: Chain A: N.57, G.60, A.61, S.64, S.65 Chain B: A.23, E.24 Ligands: ARG.1, Q95.2, ARG.4, GLN.7, TYR.8 4 PLIP interactions: 2 interactions with chain B, 2 Ligand-Ligand interactions Hydrophobic interactions: B:E.24, R.4 Hydrogen bonds: B:E.24 pi-Cation interactions: R.1

2 x TYR: TYROSINE(Non-covalent)

TYR.5: 8 residues within 4Å: Chain A: L.234 Chain C: P.4, R.5, I.6 Chain E: L.234 Ligands: ARG.1, Q95.2, GLN.6 8 PLIP interactions: 4 interactions with chain C, 2 Ligand-Ligand interactions, 1 interactions with chain A, 1 interactions with chain E Hydrophobic interactions: C:P.4, C:I.6, C:I.6, Q.6, A:L.234, E:L.234 Hydrogen bonds: C:R.5 Water bridges: R.1 TYR.8: 10 residues within 4Å: Chain B: E.24 Chain E: I.207, L.210, T.222, M.225, R.229 Ligands: ARG.1, Q95.2, Q95.3, GLN.7 8 PLIP interactions: 2 Ligand-Ligand interactions, 1 interactions with chain B, 5 interactions with chain E Hydrophobic interactions: Q.7, E:I.207, E:T.222, E:M.225 Hydrogen bonds: R.1, B:E.24, E:T.222, E:R.229

2 x GLN: GLUTAMINE(Non-covalent)

GLN.6: 6 residues within 4Å: Chain C: R.5 Chain E: R.229, D.230 Ligands: ARG.1, Q95.2, TYR.5 2 PLIP interactions: 1 interactions with chain E, 1 Ligand-Ligand interactions Water bridges: E:D.230 Hydrophobic interactions: Y.5 GLN.7: 6 residues within 4Å: Chain B: E.24 Chain E: T.222, Q.226 Ligands: Q95.3, ARG.4, TYR.8 3 PLIP interactions: 1 Ligand-Ligand interactions, 1 interactions with chain E, 1 interactions with chain B Hydrophobic interactions: Y.8 Hydrogen bonds: E:Q.226, B:E.24

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Stevers, L.M. et al., Macrocycle-stabilization of its interaction with 14-3-3 increases plasma membrane localization and activity of CFTR. Nat Commun (2022)

Release Date

2022-05-25

Peptides

14-3-3 protein theta: ABEF
Cystic fibrosis transmembrane conductance regulator: CD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

E
C

F
D

C
F

D
E

14-3-3 protein theta

Cystic fibrosis transmembrane conductance regulator

Related Entries With Identical Sequence